Please use this identifier to cite or link to this item:
|Title:||Modification of rat detrusor muscle contraction by ascorbic acid and citric acid involving enhanced neurotransmitter release and Ca2+ influx|
Elliott, Ruth A.
Tincello, Douglas G.
|Publisher:||John Wiley & Sons|
|Citation:||Neurourology and Urodynamics, 2009, 28 (6), pp. 542 - 548.|
|Abstract:||Aims:- Consumption of carbonated soft drinks is independently associated with the development of overactive bladder (OR 1.41, 95% Cl 1.02-1.95). We have shown previously that artificial sweeteners, present in carbonated soft drinks, enhanced detrusor muscle contraction. Other constituents of soft drinks are preservatives and antioxidants, we evaluated the effects of two of these, ascorbic acid and citric acid, on the contractile response of isolated rat bladder muscle strips. Methods:- Detrusor muscle strips were suspended in a perfusion organ bath. We determined the effect of ascorbic acid and citric acid on the contractile responses to electrical field stimulation (EFS) in the absence and presence of atropine, carbachol, , methylene ATP, potassium and calcium. Results:- Ascorbic acid and citric acid (10-7 M to 10-3 M) enhanced the contractile response to 10 Hz EFS compared to control (P < 0.01). The frequency and amplitude of spontaneous bladder contractions were enhanced in the presence of ascorbic acid and citric acid by 14%, 21%, 21%, and 11% respectively. Ascorbic acid 10-4 M significantly increased the atropine resistant response to EFS 5 Hz by 37% (P < 0.01) and inhibited contraction in response to carbachol 10-4 M by 24%, (P < 0.05). Both ascorbic acid 10-4 M and citric acid 10-5 M significantly enhanced maximum contractile responses to , methylene ATP, KCI and calcium compared to control. Conclusions:- Ascorbic acid and citric acid augmented bladder muscle contraction possibly by enhanced Ca2+ influx. Presynaptic neurotransmitter release was enhanced by ascorbic acid. Carbonated beverages containing preservatives may aggravate symptoms of OAB. Neurourol. Urodyn.|
|Description:||This paper was published as Neurourology and Urodynamics, 2009, 28 (6), pp. 542-548. It is available from http://www3.interscience.wiley.com/journal/122275573/abstract. Doi: 10.1002/nau.20701|
Metadata only entry
|Appears in Collections:||Published Articles, Dept. of Cancer Studies and Molecular Medicine|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.